A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis
暂无分享,去创建一个
Xiangwei Song | Shengchun Liu | Liehua Liu | Zili Wang | W. Jin | Q. Liang | Zhigang Huang | J. Fei | Huquan Yin
[1] Julie A. Johnson,et al. Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension , 2022, Frontiers in Genetics.
[2] G. Peng,et al. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway. , 2020, Neoplasma.
[3] Jiong Zhang,et al. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma , 2019, Molecular medicine reports.
[4] Yu-Jie Hou,et al. MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt/β-catenin pathway by negative regulation of Smad7 , 2019, Bioscience, biotechnology, and biochemistry.
[5] I. Adcock,et al. Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis , 2019, Disease markers.
[6] Lei Wang,et al. MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/β-catenin signaling pathway , 2018, Journal of Cancer.
[7] G. Wei,et al. Long non‐coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR‐195‐5p , 2018, Journal of cellular biochemistry.
[8] Yuan Zhou,et al. TAM 2.0: tool for MicroRNA set analysis , 2018, Nucleic Acids Res..
[9] L. Mei,et al. YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling , 2018, Bone Research.
[10] R. Dunn,et al. Spinal tuberculosis: review of current management. , 2018, The bone & joint journal.
[11] Aristeidis G. Telonis,et al. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer. , 2018, Cancer research.
[12] A. Masotti,et al. Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases , 2017, Genes.
[13] S. Gordon,et al. Circulating microRNAs as Potential Biomarkers of Infectious Disease , 2017, Front. Immunol..
[14] Yushu Bai,et al. Trends of spinal tuberculosis research (1994–2015) , 2016, Medicine.
[15] V. Prajapati,et al. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases , 2016, Front. Microbiol..
[16] A. Berchuck,et al. MicroRNAs in endometrial cancers from black and white patients. , 2015, American journal of obstetrics and gynecology.
[17] G. Kristiansen,et al. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. , 2015, The Journal of urology.
[18] K. Shroyer,et al. Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities , 2014, International journal of oncology.
[19] Jicheng Li,et al. Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis , 2013, PloS one.
[20] V. Jung,et al. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. , 2012, Cancer epidemiology.
[21] V. Wiwanitkit,et al. MicroRNA from tuberculosis RNA: A bioinformatics study. , 2012, Journal of thoracic disease.
[22] Wei Huang,et al. Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway , 2012, Acta Pharmacologica Sinica.
[23] R. Garg,et al. Spinal tuberculosis: A review , 2011, The journal of spinal cord medicine.
[24] Jessica A. Weber,et al. The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.
[25] Larry Wasserman,et al. All of Statistics: A Concise Course in Statistical Inference , 2004 .
[26] Larry Wasserman,et al. All of Statistics , 2004 .
[27] B Reiser,et al. Measuring the effectiveness of diagnostic markers in the presence of measurement error through the use of ROC curves. , 2000, Statistics in medicine.
[28] E. Nussbaum,et al. Spinal tuberculosis: a diagnostic and management challenge. , 1995, Journal of neurosurgery.
[29] Martin Chalfie,et al. Mutations that lead to reiterations in the cell lineages of C. elegans , 1981, Cell.